Edwin Harless

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Lyondell Chemical Co. manufactures and distributes chemicals & plastics, produces fuel products, and refines heavy & high-sulfur crude oil. The company operates in four segments: Ethylene Co-Products and Derivatives, Propylene Oxide & Related Products, Refining, and Inorganic Chemicals. The company's products are used in the clothing, food packaging, household furnishings, automotive parts, construction, home-building materials, paints, and coating industries. The company was founded in 1985 and is headquartered in Houston, TX.

Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.

BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA.

Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN.

The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015.

QPS LLC is a minority-owned business which provides contract research services in the United States and Taiwan. Its services include bioanalysis, hybridization, drug metabolism & pharmacokinetics, and biomarkers. QPS was founded in 1995 by Benjamin Chien and is headquartered in Newark, DE

QPS Holdings LLC provides testing services to support preclinical and clinical research and development. It services include assay finder, bioanalysis, dermal and transdermal, neuropharmacology, and toxicology. The company was founded by Benjamin M. Chien in 1995 and is headquartered in Newark, DE.

Delaware BioScience Association promotes Delaware's bioscience industry. It facilitates growth of the life science industry, advancements in research as well as supporting education initiatives in Delaware and the surrounding region. The company was founded in 2006 and is headquartered in Newark, DE.

PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA.